Last reviewed · How we verify

NCT02912416

Efficacy of Probiotics on Iron Status During Pregnancy

Completed NA Last updated 4 March 2020
What this trial tests

NA trial testing Probiotics in Prevention of Iron Deficiency in 326 participants. Completed in 11 November 2018.

Timeline
9 September 2016
Primary endpoint
11 November 2018
11 November 2018

Quick facts

Lead sponsorProbi AB
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment326
Start date9 September 2016
Primary completion11 November 2018
Estimated completion11 November 2018
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Probi AB — full company profile →

Who can join

Adults 18 to 42, female only, with Prevention of Iron Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determine the effect of probiotics on improving iron status in a population of healthy, pregnant women.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants.
    Grev J, Berg M, Soll R. · · 2018 · cited 34× · PMID 30548483 · DOI 10.1002/14651858.cd012519.pub2
  2. The effect of Lactiplantibacillus plantarum 299v together with a low dose of iron on iron status in healthy pregnant women: A randomized clinical trial.
    Axling U, Önning G, Martinsson Niskanen T, Larsson N, et al · · 2021 · cited 11× · PMID 33880752 · DOI 10.1111/aogs.14153

Verify or expand the search:

Other trials of Probiotics

Trials testing the same drug.

Other Probi AB trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02912416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing